- $737.59m
- $768.78m
- $278.42m
- 77
- 36
- 43
- 51
Annual income statement for Transcat, fiscal year end - March 29th, USD millions except per share, conversion factor applied.
2021 March 27th | 2022 March 26th | 2023 March 25th | 2024 March 30th | 2025 March 29th | |
|---|---|---|---|---|---|
| Period Length: | 52 W | 52 W | 52 W | 53 W | 52 W |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 173 | 205 | 231 | 259 | 278 |
| Cost of Revenue | |||||
| Gross Profit | 46.1 | 58.4 | 68.4 | 83.8 | 89.5 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 162 | 191 | 214 | 240 | 261 |
| Operating Profit | 11.1 | 14.1 | 16.2 | 19.8 | 17.9 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 9.98 | 13.2 | 13.5 | 18.4 | 18.3 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 7.79 | 11.4 | 10.7 | 13.6 | 14.5 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 7.79 | 11.4 | 10.7 | 13.6 | 14.5 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 7.79 | 11.4 | 10.7 | 13.6 | 14.5 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 1.11 | 1.6 | 1.42 | 1.78 | 1.61 |